期刊文献+

确认我国轮状病毒疫苗株LLR基因型为G10P[15] 被引量:25

Genotype of Rotavirus Vaccine Strain LLR in China is G10P[15]
原文传递
导出
摘要 轮状病毒是世界上引起婴幼儿重症腹泻最常见的病原体。轮状病毒感染引起的腹泻除疫苗外目前尚无特效治疗药物。我国兰州生物制品研究所采用G10型羊轮状病毒LLR疫苗株研制的口服轮状病毒活疫苗罗特威(商品名)已于2001年上市。该疫苗基因型被普遍认为是G10P[12]。为证实该疫苗的基因型,本实验采用RT-PCR方法扩增罗特威疫苗株LLR的VP7与VP4基因并进行序列测定、比对和进化分析,结果显示罗特威疫苗株LLR的VP7基因型为G10、VP4基因型为P[15]。综上罗特威疫苗株LLR基因型为G10P[15]。 Rotavirus is the leading causal agent of severe acute gastroenteritis in children aged5years.A specific pharmacologic agent for the treatment of rotavirus-infected children is lacking.In China,only the Luo Tewei oral vaccine(Lanzhou Institute of Biological Products,Shanghai,China),which is produced from Lanzhou lamb rotavirus vaccine(LLR),is available.Studies have hypothesized that the genotype of LLR is G10P[12],To identify the genotype of LLR by reverse transcription-polymerase chain reaction,we showed that the VP7 and VP4genotypes of LLR were G10 and P[15],respectively,based on sequencing,alignment and phylogenetic analyses.In conclusion,we identified the genotype of rotavirus strain LLR to be G10P[15].
出处 《病毒学报》 CAS CSCD 北大核心 2015年第2期170-173,共4页 Chinese Journal of Virology
基金 国家自然科学基金(81472003)
关键词 轮状病毒 疫苗 LLR 基因型 Rotavirus Vaccine LLR Genotype
  • 相关文献

参考文献19

  • 1Tate J E, Burton A H, Boschi-Pinto C, Steele A D, Duque J, Parashar U D. 2008 estimate of worldwide ro- tavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vac- cination programmes a systematic review and meta-a- nalysis[J]. Lancet Infect Dis. 2012 Feb 12 (2) 136- 141.
  • 2Parashar U D, Gibson C J, Bresse J S, Glass R I. Rota-virus and severe childhood diarrhea [J]. Emerg Infect Dis. 2006 Feb;12(2) :304-306.
  • 3Agocs M M, Serhan F, Yen C, Mwenda J M, de O1- iveira L H, Teleb N, Oliveira L H, Teleb N, Wasley A, Wijesinghe P R, Fox K, Tate J E, Gentsch J R, Pa- rashar U D, Kang G. WHO global rotavirus surveil- lance network.- a strategic review of the first 5 years, 2008-2012 [J]. MMWR Morb Mortal Wkly Rep. 2014 Jul 2563(29) :634-637.
  • 4Liu N, Yen C, Fang Z Y, Tate J E, Jiang B, Parashar U D, Zeng G, Duan Z J, 2012. Projected health impact and cost-effectiveness of rotavirus vaccination among children 5 years of age in China. Vaccine 30, 6940- 6945.
  • 5Projected health impact and cost-effectiveness of rotavirus vaccination among children 5 years of age in China [J]. Vaccine, 2012 Nov 630(48) :6940-6945.
  • 6李东,国泰,杨晓明.轮状病毒疫苗的研究现状[J].中国生物制品学杂志,2007,20(11):863-865. 被引量:10
  • 7郑丽舒.轮状病毒疫苗发展及现状[J].国外医学(病毒学分册),2003,10(1):1-4. 被引量:15
  • 8鞠月迎.新型轮状病毒疫苗研究进展[J].世界临床药物,2006,27(6):338-343. 被引量:4
  • 9刘娜,张爱华,安志杰,段招军.北京市丰台区某接种点国产轮状病毒口服活疫苗的使用状况分析[J].中华实验和临床病毒学杂志,2012,26(3):199-201. 被引量:5
  • 10刘娜,段招军.轮状病毒疫苗相关研究进展[J].中华实验和临床病毒学杂志,2012,26(3):236-238. 被引量:9

二级参考文献139

共引文献105

同被引文献171

引证文献25

二级引证文献176

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部